SCHEMBL25528107

SCHEMBL25528107

Cc1cn2nc(C=O)ccc2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.53
COMT P21964 1/20 0.44
PDE10A Q9Y233 4/20 0.36
CCR1 P32246 1/20 0.35
AHR P35869 2/20 0.34
PIK3CA P42336 4/20 0.33
PIK3CG P48736 4/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KCNJ1 P48048 1/20 0.32
PIK3CD O00329 2/20 0.31
PIK3CB P42338 2/20 0.31
MAP4K4 O95819 1/20 0.31
PRKACA P17612 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921056 0.77 DYRK1A (0.58) DYRK1ACOMTPDE10AAHRPIK3CA
SCHEMBL25703582 0.73 DYRK1A (0.50) DYRK1ACOMTPDE10AAHRPIK3CA
SCHEMBL1054695 0.72 DYRK1A (0.53) DYRK1ACOMTPDE10AAHRPIK3CG
SCHEMBL17856992 0.72 DYRK1A (0.53) DYRK1ACOMTPDE10AAHRPIK3CA
SCHEMBL17232819 0.72 DYRK1A (0.53) DYRK1ACOMTPDE10AAHRALDH1A1
SCHEMBL29020764 0.72 DYRK1A (0.53) DYRK1ACOMTPDE10AAHRALDH1A1
SCHEMBL477109 0.72 DYRK1A (0.53) DYRK1ACOMTPDE10AAHRALDH1A1
SCHEMBL12664115 0.71 CSNK1D (0.39) PIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL16972535 0.71 PDE10A (0.49) PDE10ACCR1
SCHEMBL18727803 0.71 PDCD1 (0.60) DYRK1AALDH1A1HPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP DYRK1A 2576/4885COMT 1058/4885PDE10A 594/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH DYRK1A 3493/4885COMT 1028/4885PDE10A 1367/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP DYRK1A 2576/4885COMT 1058/4885PDE10A 594/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP DYRK1A 2576/4885COMT 1058/4885PDE10A 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.